Royal Bank of Canada
AH

Royal Bank of Canada’s Accretive Health AH Stock Holding History

Royal Bank of Canada’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,500
Closed -$12K – 6459
2014
Q1 		$12K Hold
1,500
– – ﹤0.01% 5389
2013
Q4 		$14K Sell
1,500
-15,243
-91% -$131K ﹤0.01% 5386
2013
Q3 		$153K Buy
16,743
+15,243
+1,016% +$152K ﹤0.01% 4244
2013
Q2 		$16K Buy
+1,500
New +$15.8K ﹤0.01% 5122

Other funds holding AH

JRP
Jasper Ridge Partners Menlo Park, California $4.49B AUM 18.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
RMC
Regis Management Company Menlo Park, California $331M AUM 14.13% 1-Year Est. Return
BCM
Breithorn Capital Management New York $141M AUM 41.82% 1-Year Est. Return
ECM
EII Capital Management New York $774K AUM 22.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
MIM
Merion Investment Management Bay Harbor Islands, Florida $1.26M AUM 28.57% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
SCM
Stonebridge Capital Management Los Angeles, California $220M AUM

Royal Bank of Canada's AH Position: Q2 2014 in Review

Royal Bank of Canada sold out of Accretive Health (AH) in Q2 2014, closing a stake of 1,500 shares — an estimated $12K sold.

Royal Bank of Canada first reported a position in AH in Q2 2013 and held it in 4 quarters. The position peaked at $153K in Q3 2013. 12 funds tracked by Wall St. Rank hold AH as of Q2 2014.

  • Royal Bank of Canada reported no remaining Accretive Health position as of Q2 2014 after selling out during the quarter.
  • Royal Bank of Canada sold 1,500 Accretive Health shares in Q2 2014, an estimated $12K.
  • Royal Bank of Canada first reported a position in Accretive Health in Q2 2013 and held it in 4 quarters.
  • Royal Bank of Canada's Accretive Health position peaked at $153K in Q3 2013.
  • 12 funds tracked by Wall St. Rank held Accretive Health as of Q2 2014.

Based on Royal Bank of Canada's 13F filing for Q2 2014, filed 14 Aug 2014.